Cart
sales@molnova.com
Isovaleramide
CAS No. 541-46-8
Isovaleramide( NPS-1776 | NPS 1776 | NPS1776 | Isovaleramide )
Catalog No. M14938 CAS No. 541-46-8
Isovaleramide is an anticonvulsant molecule isolated from Valeriana pavonii, it inhibits the liver alcohol dehydrogenases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | 32 | In Stock |
|
| 500MG | 51 | In Stock |
|
| 1G | 74 | In Stock |
|
Biological Information
-
Product NameIsovaleramide
-
NoteResearch use only, not for human use.
-
Brief DescriptionIsovaleramide is an anticonvulsant molecule isolated from Valeriana pavonii, it inhibits the liver alcohol dehydrogenases.
-
DescriptionIsovaleramide is an anticonvulsant molecule isolated from Valeriana pavonii, it inhibits the liver alcohol dehydrogenases.
-
In Vitro——
-
In Vivo——
-
SynonymsNPS-1776 | NPS 1776 | NPS1776 | Isovaleramide
-
PathwayMetabolic Enzyme/Protease
-
TargetDehydrogenase
-
RecptorAlcohol DHO
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number541-46-8
-
Formula Weight101.15
-
Molecular FormulaC5H11NO
-
Purity>98% (HPLC)
-
SolubilityEthanol: 20 mg/mL (197.72 mM); DMSO: 20 mg/mL (197.72 mM)
-
SMILESCC(C)CC(N)=O
-
Chemical Name3-Methylbutanamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
CBR-5884
CBR-5884 is an ?selective, active of phosphoglycerate dehydrogenase (PHGDH) inhibitor with an IC50 of 33 μM.?CBR-5884 inhibits de novo serine synthesis in cancer cells and is selectively toxic to cancer cell lines with high serine biosynthetic activity.?
-
IDH2R140Q-IN-2
IDH2R140Q-IN-2 is an orally active and potent IDH2R140Q inhibitor with an IC50 of 29 nM.IDH2R140Q-IN-2 possesses potential antitumour activity, reducing D2HG production in TF-1 cell lines carrying the IDH2R140Q mutation (IC50 of 10 nM) and inhibiting tumour tissue D2HG levels.
-
DSM265
DSM265 (PfSPZ) is a dihydroorotic acid dehydrogenase inhibitor with antimalarial activity (IC50: 8.9 nM).DSM265 inhibits the growth of Pf3D7 parasites and can be used for the treatment and prophylaxis of malaria infections.
